Eva M Martínez-Cáceres (Eva Martínez-Cáceres)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Platelet Rich Plasma

Pseudomonas Aeruginosa

Multiple Sclerosis

Epstein Barr Virus

Top Venues

International journal of molecular sciences

Journal of clinical medicine

Immunotherapy advances

This page only lists publications with an associated author ORCID identifier.

Publications

Oscar-Danilo Ortega-Hernandez, Eva M Martínez-Cáceres, Silvia Presas-Rodríguez, Cristina Ramo Tello
Epstein-Barr Virus and Multiple Sclerosis: A Convoluted Interaction and the Opportunity to Unravel Predictive Biomarkers. International journal of molecular sciences 24 (8) (2023)
Oscar-Danilo Ortega-Hernandez, Eva M Martínez-Cáceres, Silvia Presas-Rodríguez, Cristina Ramo Tello
Epstein-Barr Virus and Multiple Sclerosis: A Convoluted Interaction and the Opportunity to Unravel Predictive Biomarkers. International journal of molecular sciences 24 (8) (2023)
María José Mansilla, Catharien M U Hilkens, Eva M Martínez-Cáceres
Challenges in tolerogenic dendritic cell therapy for autoimmune diseases: the route of administration. Immunotherapy advances 3 (1) (2023)
Oscar-Danilo Ortega-Hernandez, Eva M Martínez-Cáceres, Silvia Presas-Rodríguez, Cristina Ramo Tello
Epstein-Barr Virus and Multiple Sclerosis: A Convoluted Interaction and the Opportunity to Unravel Predictive Biomarkers. International journal of molecular sciences 24 (8) (2023)
Paola Zuluaga, Aina Teniente-Serra, Daniel Fuster, Bibiana Quirant-Sánchez, Anna Hernández-Rubio, Eva M Martínez-Cáceres, Roberto Muga
Increased Natural Killer Cells Are Associated with Alcohol Liver Fibrosis and with T Cell and Cytotoxic Subpopulations Change. Journal of clinical medicine 11 (2) (2022)
María José Mansilla, Íñigo González-Larreategui, Neus Figa-Martín, Jaume Barallat, Federico Fondelli, Ares Sellés-Rius, Bibiana Quirant-Sánchez, Aina Teniente-Serra, Eva M Martínez-Cáceres
Transfection of Vitamin D3-Induced Tolerogenic Dendritic Cells for the Silencing of Potential Tolerogenic Genes. Identification of CSF1R-CSF1 Signaling as a Glycolytic Regulator. International journal of molecular sciences 22 (14) (2021)